YM-53601 is a small-molecule squalene synthase (FDFT1) inhibitor used in biochemical and pharmacology research to modulate cholesterol and triglyceride biosynthesis. It has demonstrated lipid-lowering effects in vivo and is supplied as a solid or as ready-to-use DMSO solutions for laboratory assays.
- Inhibits squalene synthase (FDFT1) with reported IC50 ≈ 79 nM.
- Reduces plasma cholesterol and triglyceride levels in animal studies.
- Useful for studying lipid metabolism and hepatitis C virus propagation.
- Available as solid and 10 mM DMSO solution for assay flexibility.
- High purity suitable for biochemical and pharmacological assays.
- Comes with QC documents such as data sheet, SDS, COA, HNMR, and LCMS.